Insights on urinary NGAL obtained in a primary care setting

Clinica Chimica Acta

Volumn 413, Issue 7-8, 2012, Pages 733-739

  Tomonaga, Yuki ^a   Szucs, Thomas ^b   Ambühl, Patrice ^c   Nock, Stefan ^c   Risch, Martin ^e,f   Risch, Lorenz ^d,f,g  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c Stadtspital Waid   (Switzerland)

^d Private University Liechtenstein   (Liechtenstein)

^e Central Laboratory   (Switzerland)

^f Labormedizinische Zentren Dr Risch   (Switzerland)

^g INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Acute kidney injury; Albuminuria; Chronic kidney disease; Glomerular filtration rate; NGAL; Primary care

Indexed keywords

C REACTIVE PROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; AGE DISTRIBUTION; ALBUMINURIA; ANALYTICAL PARAMETERS; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GENERAL PRACTITIONER; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION TEST; LABORATORY DIAGNOSIS; LEUKOCYTE COUNT; LIVER FUNCTION; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN URINE LEVEL; REFERENCE VALUE; SEX RATIO;

ACUTE-PHASE PROTEINS; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIPOCALINS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PROTO-ONCOGENE PROTEINS;

EID: 84857640738     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.01.001     Document Type: Article

References (46)

1. Kjeldsen L., Johnsen A.H., Sengelov H., Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993, 268:10425-10432.
2. Cowland J.B., Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 1997, 45:17-23.
3. Devarajan P. Review: neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology (Carlton) 2010, 15:419-428.
4. Mishra J., Dent C., Tarabishi R., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005, 365:1231-1238.
5. Nash K., Hafeez A., Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002, 39:930-936.
6. Ricci Z., Cruz D., Ronco C. The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int 2008, 73:538-546.
7. Joannidis M., Druml W., Forni L.G., et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM. Intensive Care Med 2010, 36:392-411.
8. Grenier F.C., Ali S., Syed H., et al. Evaluation of the ARCHITECT urine NGAL assay: assay performance, specimen handling requirements and biological variability. Clin Biochem 2010, 43:615-620.
9. Perrone R.D., Madias N.E., Levey A.S. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992, 38:1933-1953.
10. Khalil P., Murty P., Palevsky P.M. The patient with acute kidney injury. Prim Care 2008, 35:239-264. vi.
11. Weber C.L., Bennett M., Er L., Bennett M.T., Levin A. Urinary NGAL levels before and after coronary angiography: a complex story. Nephrol Dial Transplant 2011, 26:3207-3211.
12. Levey A.S., Stevens L.A., Schmid C.H., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
13. Risch L., Saely C.H., Neyer U., et al. Prevalence of decreased glomerular filtration rate in patients seeking non-nephrological medical care - an evaluation using IDMS-traceable creatinine based MDRD as well as Mayo Clinic quadratic equation estimates. Clin Chim Acta 2007, 378:71-77.
14. Levey A.S., de Jong P.E., Coresh J., et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011, 80:17-28.
15. Haase M., Bellomo R., Devarajan P., Schlattmann P., Haase-Fielitz A. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009, 54:1012-1024.
16. Haase M., Devarajan P., Haase-Fielitz A., et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol 2011, 57:1752-1761.
17. Wetzels J.F., Kiemeney L.A., Swinkels D.W., Willems H.L., den Heijer M. Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 2007, 72:632-637.
18. Soni S.S., Cruz D., Bobek I., et al. NGAL: a biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol 2010, 42:141-150.
19. Strong R.K., Bratt T., Cowland J.B., Borregaard N., Wiberg F.C., Ewald A.J. Expression, purification, crystallization and crystallographic characterization of dimeric and monomeric human neutrophil gelatinase associated lipocalin (NGAL). Acta Crystallogr D Biol Crystallogr 1998, 54:93-95.
20. Goetz D.H., Holmes M.A., Borregaard N., Bluhm M.E., Raymond K.N., Strong R.K. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 2002, 10:1033-1043.
21. Schmidt-Ott K.M., Mori K., Li J.Y., et al. Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2007, 18:407-413.
22. Bolignano D., Coppolino G., Romeo A., et al. Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients. Nephrol Dial Transplant 2009, 24:3398-3403.
23. Decavele A.S., Dhondt L., De Buyzere M.L., Delanghe J.R. Increased urinary neutrophil gelatinase associated lipocalin in urinary tract infections and leukocyturia. Clin Chem Lab Med 2011, 49:999-1003.
24. Erley C.M., Bader B.D., Berger E.D., et al. Plasma clearance of iodine contrast media as a measure of glomerular filtration rate in critically ill patients. Crit Care Med 2001, 29:1544-1550.
25. Wells M., Lipman J. Pitfalls in the prediction of renal function in the intensive care unit. A review. S Afr J Surg 1997, 35:16-19.
26. Bagshaw S.M., Gibney R.T. Conventional markers of kidney function. Crit Care Med 2008, 36:S152-S158.
27. Waikar S.S., Sabbisetti V.S., Bonventre J.V. Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney Int 2010, 78:486-494.
28. Damman K., van Veldhuisen D.J., Navis G., Voors A.A., Hillege H.L. Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure. Eur J Heart Fail 2008, 10:997-1000.
29. Haase M., Mertens P.R., Haase-Fielitz A. Renal stress in vivo in real-time - visualised by the NGAL reporter mouse. Nephrol Dial Transplant 2011, 26:2109-2111.
30. Paragas N., Qiu A., Zhang Q., et al. The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med 2011, 17:216-222.
31. Bolignano D., Lacquaniti A., Coppolino G., et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol 2009, 4:337-344.
32. Bolignano D., Lacquaniti A., Coppolino G., Campo S., Arena A., Buemi M. Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease. Kidney Blood Press Res 2008, 31:255-258.
33. Bolignano D., Coppolino G., Lacquaniti A., Nicocia G., Buemi M. Pathological and prognostic value of urinary neutrophil gelatinase-associated lipocalin in macroproteinuric patients with worsening renal function. Kidney Blood Press Res 2008, 31:274-279.
34. Mitsnefes M.M., Kathman T.S., Mishra J., et al. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol 2007, 22:101-108.
35. James M.T., Hemmelgarn B.R., Wiebe N., et al. Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet 2010, 376:2096-2103.
36. Grams M., Coresh J. Proteinuria and risk of acute kidney injury. Lancet 2010, 376:2046-2048.
37. Thakar C.V., Christianson A., Himmelfarb J., Leonard A.C. Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus. Clin J Am Soc Nephrol 2011, 6:2567-2572.
38. Bydash J.R., Ishani A. Acute kidney injury and chronic kidney disease: a work in progress. Clin J Am Soc Nephrol 2011, 6:2555-2557.
39. Stevens L.A., Coresh J., Schmid C.H., et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008, 51:395-406.
40. Taglieri N., Koenig W., Kaski J.C. Cystatin C and cardiovascular risk. Clin Chem 2009, 55:1932-1943.
41. Zhang Z., Lu B., Sheng X., Jin N. Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis. Am J Kidney Dis 2011, 58:356-365.
42. Poniatowski B., Malyszko J., Bachorzewska-Gajewska H., Malyszko J.S., Dobrzycki S. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in patients with chronic heart failure and coronary artery disease. Kidney Blood Press Res 2009, 32:77-80.
43. Smith E.R., Zurakowski D., Saad A., Scott R.M., Moses M.A. Urinary biomarkers predict brain tumor presence and response to therapy. Clin Cancer Res 2008, 14:2378-2386.
44. Manfredi M.A., Zurakowski D., Rufo P.A., Walker T.R., Fox V.L., Moses M.A. Increased incidence of urinary matrix metalloproteinases as predictors of disease in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2008, 14:1091-1096.
45. Fernandez C.A., Yan L., Louis G., Yang J., Kutok J.L., Moses M.A. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res 2005, 11:5390-5395.
46. Nickolas T.L., O'Rourke M.J., Yang J., et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008, 148:810-819.